arginine has been researched along with vitamin k semiquinone radical in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (22.22) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Krone, CL | 1 |
| Akerblom, H | 1 |
| Hirai, M; Kojima, T; Matsushita, T; Saito, H; Shimizu, A; Sugiura, I | 1 |
| Furie, B; Furie, BC; Grant, MA; Huang, G; Huang, M; Morelli, X; Rigby, AC; Seaton, B | 1 |
| GIRARD, M | 1 |
| FINKEL, M; HARRIS, RE; MCPHAUL, JJ; MILLER, MB; WEG, JG; WILTSIE, DS | 1 |
| Rothery, RA; Weiner, JH; Zhao, Z | 1 |
| Jolicoeur, EM; Lopes, RD; Ohman, EM; Wang, T | 1 |
| Breddin, HK; Drenth, AF; Harder, S; Hoppensteadt, DA; Mayuga, M; Osakabe, M; Prechel, M; Walenga, JM; Watanabe, H | 1 |
| Ortel, TL | 1 |
| Antovic, JP; Armstrong, E; Baghaei, F; Dalsgaard-Nielsen, J; Hillarp, A; Holme, PA; Holmström, M; Johnsson, H; Joutsi-Korhonen, L; Lassila, R; Sandset, PM | 1 |
| Pötzsch, B | 1 |
| Agewall, S; Atar, D; Drexel, H; Husted, SE; Kaski, JC; Kjeldsen, K; Koller, L; Lewis, BS; Lip, GYH; Morais, J; Niessner, A; Storey, RF; Tamargo, J; Torp-Pedersen, C; Verheugt, FWA; Wassmann, S | 1 |
| Ansell, JE | 1 |
| Cornelius, CC; Cripps, MW; Gales, PE; Nakonezny, PA; Vazquez, N; Wey, JC | 1 |
| Ageno, W; Agnelli, G; Chan, NC; De Caterina, R; Diener, HC; Hylek, E; Lip, GYH; Raskob, GE; Siegal, DM; Verheugt, FWA; Weitz, JI | 1 |
| Bergis, B; Chanson, N; Chassin, O; Drouot, S; Gleizes, O; Legris, N; Proulle, V; Ract, C; Walle, EM; Werner, M | 1 |
| Legault, J; Mirault, ME; Ramotar, D; Tremblay, A | 1 |
6 review(s) available for arginine and vitamin k semiquinone radical
| Article | Year |
|---|---|
New approaches in the management of fulminant hepatic failure.
Topics: Adult; Animals; Arginine; Exchange Transfusion, Whole Blood; Extracorporeal Circulation; Female; Glucocorticoids; Glucose; Growth Hormone; Hepatic Encephalopathy; Humans; Liver; Neomycin; Papio; Parabiosis; Perfusion; Vitamin K | 1971 |
Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
Topics: Algorithms; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Chondroitin Sulfates; Comorbidity; Dermatan Sulfate; Drug Therapy, Combination; Fibrinolytic Agents; Fondaparinux; Heparin; Heparinoids; Heparitin Sulfate; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Syndrome; Thrombocytopenia; Vitamin K | 2007 |
Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
Topics: Anticoagulants; Arginine; Autoantibodies; Contraindications; Disseminated Intravascular Coagulation; Fondaparinux; Heparin; Hirudins; Humans; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombophilia; Time Factors; Venous Thromboembolism; Vitamin K; Warfarin | 2009 |
[Anticoagulation].
Topics: Administration, Oral; Anticoagulants; Antithrombins; Arginine; Arrhythmias, Cardiac; Blood Coagulation Tests; Factor Xa Inhibitors; Hemorrhage; Heparin; Heparinoids; Hirudins; Humans; Infusions, Intravenous; Orthopedic Procedures; Peptide Fragments; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Risk Factors; Secondary Prevention; Sulfonamides; Thromboembolism; Treatment Outcome; Venous Thrombosis; Vitamin K | 2013 |
Reversing the Effect of Oral Anticoagulant Drugs: Established and Newer Options.
Topics: Administration, Oral; Animals; Antibodies, Monoclonal, Humanized; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Arginine; Blood Coagulation Disorders; Blood Coagulation Factors; Coagulants; Combined Modality Therapy; Dabigatran; Drugs, Investigational; Enoxaparin; Factor Xa; Fibrinolytic Agents; Humans; Piperazines; Practice Guidelines as Topic; Recombinant Proteins; Vitamin K | 2016 |
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.
Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Atrial Fibrillation; Benzamides; Biomarkers; Blood Coagulation; Clinical Trials as Topic; Dabigatran; Drug Administration Schedule; Factor Xa; Heart Diseases; Humans; Piperazines; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Risk; Rivaroxaban; Stroke; Thiazoles; Thrombin; Venous Thromboembolism; Vitamin K; Warfarin | 2019 |
12 other study(ies) available for arginine and vitamin k semiquinone radical
| Article | Year |
|---|---|
Mushroom poisoning due to destroying angel (Amanital virosa). A report of four cases in children.
Topics: Arginine; Child; Choline; Female; Humans; Hydrocortisone; Male; Mushroom Poisoning; Toxins, Biological; Vitamin B Complex; Vitamin K | 1968 |
Identification of the five hydrophilic residues (Lys-217, Lys-218, Arg-359, His-360, and Arg-513) essential for the structure and activity of vitamin K-dependent carboxylase.
Topics: Alanine; Amino Acids, Essential; Animals; Arginine; Carbon-Carbon Ligases; Cattle; CHO Cells; Cricetinae; Cross-Linking Reagents; Enzyme Activation; Epoxy Compounds; Factor IX; Histidine; Lysine; Mutation; Protein Precursors; Recombinant Proteins; Structure-Activity Relationship; Vitamin K | 1998 |
Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins.
Topics: 1-Carboxyglutamic Acid; Amino Acid Sequence; Animals; Arginine; Binding Sites; Blood Coagulation; Calcium; Cattle; Cell Membrane; Crystallography, X-Ray; Ions; Lysophospholipids; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Sequence Data; Peptides; Protein Binding; Protein Structure, Tertiary; Prothrombin; Vitamin K | 2003 |
[THE TREATMENT OF ALCOHOLIC CIRRHOSIS].
Topics: Adrenal Cortex Hormones; Alcoholism; Arginine; Diet; Diet Therapy; Diuretics; Folic Acid; Glutamates; Humans; Lipotropic Agents; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Extracts; Malates; Pterins; RNA; Spironolactone; Sulfonamides; Vitamin B Complex; Vitamin K | 1963 |
TREATMENT OF HEPATIC COMA BY HEMODIALYSIS.
Topics: Adolescent; Arginine; Dialysis; Enema; Glucose; Hepatic Encephalopathy; Hepatitis; Hepatitis A; Humans; Hydrocortisone; Liver Diseases; Mortality; Neomycin; Pathology; Renal Dialysis; Vitamin K | 1964 |
Effects of site-directed mutations on heme reduction in Escherichia coli nitrate reductase A by menaquinol: a stopped-flow study.
Topics: Arginine; Electron Transport; Escherichia coli Proteins; Heme; Histidine; Hydroxyquinolines; Mutagenesis, Site-Directed; Naphthols; Nitrate Reductase; Nitrate Reductases; Nitrates; Oxidation-Reduction; Polyenes; Spectrometry, Fluorescence; Terpenes; Tyrosine; Vitamin K | 2003 |
Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effect on coagulation factor testing.
Topics: Acenocoumarol; Administration, Oral; Adult; Anticoagulants; Arginine; Blood Coagulation Factors; Blood Coagulation Tests; Humans; Infusions, Intravenous; International Normalized Ratio; Male; Phenprocoumon; Pipecolic Acids; Sulfonamides; Thrombin; Vitamin K | 2008 |
Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Cardiac Catheterization; Cardiac Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Male; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vascular Surgical Procedures; Vitamin K; Young Adult | 2011 |
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharm
Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Arginine; Consensus; Dabigatran; Evidence-Based Medicine; Factor Xa; Forecasting; Hemorrhage; Humans; Piperazines; Recombinant Proteins; Risk Factors; Thrombosis; Vitamin K | 2017 |
In vitro effects of a kaolin-coated hemostatic dressing on anticoagulated blood.
Topics: Adult; Anticoagulants; Antithrombins; Arginine; Bandages; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Factor Xa Inhibitors; Hemostatics; Heparin; Humans; Kaolin; Pipecolic Acids; Platelet Aggregation Inhibitors; Prospective Studies; Rivaroxaban; Sulfonamides; Viscoelastic Substances; Vitamin K | 2018 |
[Complex management of type 2 heparin-induced thrombocytopenia in patients with major bleeding tendency: two case report].
Topics: 4-Hydroxycoumarins; Aged; Anticoagulants; Arginine; Blood Coagulation Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Hemorrhage; Heparin; Humans; Indenes; Intracranial Thrombosis; Male; Middle Aged; Neurosurgical Procedures; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Vitamin K | 2020 |
Clusters of S1 nuclease-hypersensitive sites induced in vivo by DNA damage.
Topics: Animals; Antineoplastic Agents; Catalysis; Chromatin; Deoxyribonuclease IV (Phage T4-Induced); DNA; DNA Damage; DNA Nucleotidylexotransferase; DNA-(Apurinic or Apyrimidinic Site) Lyase; DNA-Directed DNA Polymerase; Escherichia coli Proteins; Hemostatics; Humans; Lyases; Methyl Methanesulfonate; Mice; Mice, Inbred C57BL; Single-Strand Specific DNA and RNA Endonucleases; Streptonigrin; Teniposide; Tumor Cells, Cultured; Viral Proteins; Vitamin K | 1997 |